Gross Seth A, Wolfsen Herbert C
Division of Gastroenterology, Norwalk Hospital, Norwalk, CT 06856, USA.
Gastrointest Endosc Clin N Am. 2010 Jan;20(1):35-53, vi. doi: 10.1016/j.giec.2009.07.008.
Photodynamic therapy (PDT) is a drug and device therapy using photosensitizer drugs activated by laser light for mucosal ablation. Porfimer sodium PDT has been used extensively with proven long-term efficacy and durability for the ablation of Barrett esophagus and high-grade dysplasia. and early esophageal adenocarcinoma. However, continued use is hampered by an associated stricture risk and prolonged photosensitivity (4-6 weeks). Promising single-center European studies using other forms of PDT, such as aminolevulinic acid PDT, have not been replicated elsewhere, limiting the widespread use of other forms of PDT. Future use of PDT in esophageal disease depends on the development of improved dosimetry and patient selection to optimize treatment outcomes, while minimizing adverse events and complications.
光动力疗法(PDT)是一种药物与设备联合的治疗方法,它使用由激光激活的光敏药物来进行黏膜消融。卟吩姆钠光动力疗法已被广泛应用,在消融巴雷特食管、高级别异型增生及早期食管腺癌方面具有经证实的长期疗效和持久性。然而,持续使用受到相关狭窄风险和延长的光敏性(4 - 6周)的阻碍。使用其他形式光动力疗法(如氨基乙酰丙酸光动力疗法)的有前景的欧洲单中心研究尚未在其他地方得到重复,限制了其他形式光动力疗法的广泛应用。光动力疗法在食管疾病中的未来应用取决于改进剂量测定法和患者选择的发展,以优化治疗效果,同时将不良事件和并发症降至最低。